Forbion invests in transformative biotech and sustainability-driven companies that deliver measurable societal and environmental impact alongside financial returns. Their BioEconomy fund targets planetary health challenges (e.g., food security, circular materials), while their core biotech focus accelerates breakthrough therapies. With a 20-year track record, they prioritize investments with dual objectives: scientific/financial success and positive societal/planetary outcomes.
Preferred startup development maturity for initial funding deployment.
Groundbreaking biotech innovations and sustainable solutions that improve human and planetary health, including drug development, sustainable food/agriculture, materials, and environmental technologies.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
